Literature DB >> 8162421

Human and simian immunodeficiency viruses: virus-receptor interactions.

N Signoret1, P Poignard, D Blanc, Q J Sattentau.   

Abstract

The major cellular receptor for the primate immunodeficiency viruses is the CD4 molecule. As well as mediating virion attachment to the cell surface, CD4 is thought to activate the viral fusion pathway. CD4 is not, however, sufficient for viral entry; other molecules are probably involved, and in certain circumstances these may substitute for CD4. Viral tropism and cytopathogenicity are also influenced by receptor interactions.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8162421     DOI： 10.1016/0966-842x(93)90072-y

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  11 in total

1.  Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.

Authors:  B Labrosse; O Pleskoff; N Sol; C Jones; Y Hénin; M Alizon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Papillomavirus capsid binding and uptake by cells from different tissues and species.

Authors:  M Müller; L Gissmann; R J Cristiano; X Y Sun; I H Frazer; A B Jenson; A Alonso; H Zentgraf; J Zhou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

3.  Persistent infection promotes cross-species transmissibility of mouse hepatitis virus.

Authors:  R S Baric; E Sullivan; L Hensley; B Yount; W Chen
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

Authors:  B D Zelus; D R Wessner; R K Williams; M N Pensiero; F T Phibbs; M deSouza; G S Dveksler; K V Holmes
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  T Dragic; L Picard; M Alizon
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.

Authors:  I Lazaro; D Naniche; N Signoret; A M Bernard; D Marguet; D Klatzmann; T Dragic; M Alizon; Q Sattentau
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.

Authors:  O Pleskoff; M Seman; M Alizon
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C.

Authors:  Jamie J Breslin; Irene Mørk; M K Smith; Lotte K Vogel; Erin M Hemmila; Aurelio Bonavia; Pierre J Talbot; Hans Sjöström; Ove Norén; Kathryn V Holmes
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Expression of HIV receptors, alternate receptors and co-receptors on tonsillar epithelium: implications for HIV binding and primary oral infection.

Authors:  Renu B Kumar; Diane M Maher; Mark C Herzberg; Peter J Southern
Journal:  Virol J       Date:  2006-04-06       Impact factor: 4.099

10.  Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.

Authors:  P Poignard; T Fouts; D Naniche; J P Moore; Q J Sattentau
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.